TABLETABILITY, COMPACTABILITY, AND COMPRESSIBILTY: WHAT S THE DIFFERENCE?

Similar documents
f a c t s T C C T B Tricalcium citrate as excipient for direct compression

Tricalcium citrate as excipient for direct compression

R&D TO PRODUCT: HOW TO REDUCE COSTLY SCALE-UP PROBLEMS

MULTI-TIP PUNCHES AND THEIR IMPACTS ON COMPRESSION FORCES

Tablet formulation design spaces for direct compression and roller compaction. QbD in Pharmaceutical Development: processes

Maximizing Roller Compaction Benefits with Proper Excipient Selection

Variation and Risk Analysis in Tablet Press Control for Continuous Manufacturing of Solid Dosage via Direct Compaction

Scientific and Regulatory challenges in Quality by Design (QbD) submissions

Better wet granulation: development, scale-up and manufacture

EMCOMPRESS. Calcium Hydrogen Phosphate, Ph.Eur., E 341(ii) Dibasic Calcium Phosphate, USP/NF, FCC. A Proven Excipient for more than 60 Years

University of Sulaimani College of Pharmacy Dept. of Pharmaceutics 5 th stage Second Semester

Applied Process Understanding in Drug Product Development

Application Studies using the GTP at an Excipient Manufacturer s Laboratory

Preparation of Antipyretic Analgesic by Direct Compression and Its Evaluation

Tuesday, February 3 rd, 2015 University of Eastern Finland, Tietoteknia building, lecture room 1035

Typical excipients in a tablet formulation. Glidant SiO 2

Microcrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate

Streamlined Manufacture of Modified Release Matrix Tablets via Direct Compression. Katie Hewlett, Dow Gus LaBella, Colorcon

In the normal process of developing formulations, and in the routine manufacture of tablets, various defects are observed. Sometimes, the source of

PAT in Action: A Lifecycle Approach to Applied Process Understanding to set meaningful process and product specifications October, Heidelberg, Germany

ADVANTAGES OF MULTIPARTICULATES (PELLETS):

Impact factor: 3.958/ICV: 4.10 ISSN:

Roller Compaction: New trends, challenges and solutions

Roller compactors for the pharmaceutical industry. BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma

tabletting Assessing the performance of a co-processed HPMC-lactose excipient using an instrumented tablet press

Author: Takashi Osamura, Yoshiko Takeuchi, Risako Onodera, Masahiro Kitamura, Yoshiteru Takahashi, Kohei Tahara, Hirofumi Takeuchi

Engineering in Chemical and Pharmaceutical Processes. Compressing the powder between two surfaces

Best Practices for Effective Tablet Lubrication

New Developments in Spray-Dried Lactose

Introduction to tableting by direct compression

MEETING YOUR CHALLENGES TODAY AND TOMORROW. Avicel PH BINDERS

Direct Compression Microcrystalline Cellulose Grade 12 versus Classic Grade 102

Compression Physics in the Formulation Development of Tablets

Providing insight into pharmaceutical formulations

Quantifying the impact of humidity on powder properties

Manufacturing Technology Committee Risk Management Working Group Risk Management Case Studies. Case No. RMWG-07. Space

Powder Technology 207 (2011) Contents lists available at ScienceDirect. Powder Technology. journal homepage:

NATOLI AIM SOFTWARE. for data acquisition, analysis, and control systems. natoli.com

The Effect of Crystalline and Amorphous Lactose on Mechanical Properties of Roller. Compaction Ribbon and Tablets. Kim Gochioco. Master of Science.

How to Identify Critical Quality Attributes and Critical Process Parameters

The Value of High-Functionality Excipients in Continuous Manufacturing Tony Carpanzano, B.S., R. Ph. Director, R&D JRS Pharma, LP, Patterson, NY

Yoshiaki KAWASHIMA, Misato IMAI, Hirofumi TAKEUCHI, Hiromitsu YAMAMOTO and Kazunori KAMIYA Gifu Pharmaceutical University.

QbD QUANTITATIVE MEASUREMENTS OF CQAS IN SOLID DOSAGE FORM UNIT OPERATIONS

Copyright CSC Publishing

PHARMACEUTICAL MANUFACTURING

Functionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients

MANUFACTURING TECHNOLOGY

Anisotropy in Compacted Pharmaceutical Powders

5. INVESTIGATION OF POROSITY IN THE PASTILLES

Implementation of QBD for Analytical Methods - Session Introduction -

WHY IS RHEOLOGY IMPORTANT FOR SHOTCRETE AND HOW IT CAN BE IMPROVED

Kollidon SR: A polyvinyl acetate based excipient for DCsustained-release

Research paper Crushing strength, disintegration time and weight variation of tablets compressed from three Avicel PH grades and their mixtures

The research work highlights the development and evaluation of. bioavailability of drugs. The buccal route can bypass the first-pass

Welcome to ENR116 Engineering Materials. This lecture summary is part of module 2, Material Properties.

Metal Forming Process. Prof.A.Chandrashekhar

Table 1. Particle size distributions and peroxide levels of various superdisintegrants. D50 (μm) D10 (μm)

Combining crystal structure and interaction topology for interpreting functional molecular solids: A study of theophylline cocrystals

FBRM in the Formulation Development Lab: A Study of Particle Behavior during Granulation and Dissolution

INFLUENCE OF CONCENTRATION OF MODIFIED MAIZE STARCH ON COMPACTION CHARACTERISTICS AND MECHANICAL PROPERTIES OF PARACETAMOL TABLET FORMULATIONS

Manufacture of Granulations Part 4. Industrial pharmacy 5 th class 1 st semester

Formulation and Evaluation of Telmisartan with Hydrochlorothiazide Conventional Release Tablets

PHARMACEUTICAL PRINCIPLES OF SOLID DOSAGE FORMS

Content PART I: ANDA Roadmap PART II: Understanding of CPPs & CQAs PART III: Scale-Up and Technology Transfer PART IV: Process Validation & Sampling 2

New direct method to measure true density of powders during tablet compression and a modified method to draw Heckel plot. Osmo Antikainen 2015

Title: Prediction of effects of punch shapes on tableting failure by using a multi-functional single-punch tablet press

Measuring and understanding. of powders with the FT4 Powder Rheometer. freemantechnology

Pharma & Food Solutions. ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications

The Compaction of Pharmaceutical Powders

CHAPTER 5 FRESH AND HARDENED PROPERTIES OF CONCRETE WITH MANUFACTURED SAND

ICH Q9 An Industry Perspective: Ensuring Quality to Patients in a Risk-Based Regulatory Environment

Co-Processed Lactosebased excipients for Direct Compression. Ulrich Marcher Meggle GmbH & Co. KG, Germany

A Framework and Case Study for Implementing the New Process Validation Guidance

CURRENT CHALLENGES IN GLOBAL REGULATORY COMPLIANCE QUALITY OF PHARMACEUTICAL INGREDIENTS PHARMACOPOEIAL HARMONISATION PROCESS

Application as liquid carrier

Stage 3 - Process Validation: Measuring what matters

Hydroxypropylcellulose Polymer Molecular Weight: Influence on Erodible Modified Release Matrix Systems By T. Dürig, W.W. Harcum, and R. A.

1. 3 Extrusion molding

International Journal of Innovative Pharmaceutical Sciences and Research

Compaction behavior of isomalt after roll compaction

Effect of flow and packing properties on pneumatic conveying of powdered mixtures for direct compression

Technical brochure FlowLac

NISSO HPC for Pharmaceutical Applications

Pharma Ingredients & Services. Ludiflash. Technical Information

Formulation and in vitro evaluation of bosentan osmatic controlled release tablets

COMPARISON OF MAGNETICALLY ASSISTED IMPACTION COATING (MAIC) WITH TRADITIONAL MIXING TECHNIQUES FOR THE ADDITION OF A SILICA FLOW AID

THE PROCESS VALIDATION OF TABLET CONTAINING IRBESARTAN 300MG AND HYDROCHLOROTHIAZIDE 12.5mg Zamir Hussain, Baqir Shyum Naqvi & Muhammad Iqbal Nasiri

Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation

IJPRD, 2011; Vol 4(06): August-2012 ( ) International Standard Serial Number

Effect of acid treatment on the consolidation and plasto-elasticity of tapioca powder

Physical Properties and Compact Analysis of Commonly Used Direct Compression Binders Submitted: April 18, 2003; Accepted: October 9, 2003

GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES

Raman mapping to identify dry and wet states of pharmaceutical components in a hydroxypropyl methylcellulose (HPMC) hydrophilic matrix tablet

Quality by Design (QbD)

Continuous Manufacturing. Combined approved technologies swiss made. Prospekt Nr. 655

Regulatory Assessment

Comparison of the Performance of Single Punch and Rotary Tablet Presses from Different Vendors

Ranjith Reddy Kondeti et al., Asian Journal of Pharmaceutical Technology & Innovation, 02 (07); 2014; Research Article

Prediction of suitable amounts of water in fluidized bed granulation of pharmaceutical formulations using corresponding values of components

Mechanical characterization of pharmaceutical solids: A comparison between rheological tests performed under static and dynamic porosity conditions

Transcription:

WHITEPAPER TABLETABILITY, COMPACTABILITY, AND COMPRESSIBILTY: WHAT S THE DIFFERENCE? { To patients and consumers, tablets are a simple and convenient dosage form. But the science behind compressing a block of particles or granules into a single tablet can be complicated. That s where common compression studies can help. This article explains how to develop tabletability, compactibility, and compressibility profiles. Advances in compaction science have been instrumental in improving tablet product development, scale-up, and manufacturing. Today, a variety of tools can help formulators, product developers, and other industry professionals to better understand the manufacturing science and engineering behind this ubiquitous solid dosage form. These tools enable us to study tablet performance at the development stage using small quantities of material. This whitepaper describes how to conduct common compression studies, including how to develop profiles of tabletability, compactibility, and compressibility. Those terms which are commonly misused have specific meanings and offer different ways to characterize the material under compression. There are many factors that influence successful tablet manufacture, including a properly trained staff, a tablet press engineered for your product s specifications, high-quality and precisely machined compression tooling, and powder with favorable characteristics. In fact, variability in powder performance is a common issue across the pharmaceutical and dietary supplement industries. Thankfully, a number of techniques will help you understand and resolve problems Natoli Engineering Company 636.926.8900 info@natoli.com 1 / 6

with powders. First, however, make sure that a poor-quality tablet press or substandard compression tools are not part of the equation. You need good, reliable equipment to remediate tablet manufacturing issues, which typically arise unexpectedly. While understanding tablet compression is critical, the processes that precede tabletting are also very important. You must understand how particle and powder characteristics affect a tablet s quality attributes. Particle characteristics include shape, size, and size distribution, and variability in those properties can cause issues with weight, content uniformity, segregation, compression, and dissolution. The presence of a few overly large particles, for example, can lead to lower tablet weights because tablet dies are filled volumetrically. The large particles could also prolong dissolution because they would decrease the tablet s total surface area. The presence of overly small particles would have the inverse effect. The powder s characteristics including its flowability and the bulk, tapped, and true density will also have an impact on the tabletting process. True or absolute density the density once all voids are removed can be measured using a helium pycnometer. This is a useful value because it represents the tablet s density if the compression event were to expel all the air between the particles, including from inter-particulate and intra-particulate voids. Once you ve characterized the particles and powder, decide whether direct compression the simplest approach is acceptable. If not, you ll need to engineer the powder, typically by dry or wet granulation. You must also understand how the powder behaves under different loading conditions. It s the only path to the success in producing a robust tablet that you can scale to high-speed manufacturing. Ideally, you will learn how the material deforms to help you develop the formulation. Natoli Engineering Company 636.926.8900 info@natoli.com 2 / 6

TABLET COMPRESSION PROCESS The studies described here were performed on a singlestation tablet press. But whether your compression machine uses a single punch and a hand-filled die or is a rotary press with a gravity or force feeding system, the process is similar: The material undergoes compressive forces in a confined space, causing a reduction in volume. At first, the low applied pressure causes particles to rearrange and pack more closely, and porosity thus decreases. As pressure increases, the dimensions of the particles change. They can either A single-station tablet press for conducting compression studies. fracture into smaller discrete particles (fragmentation) or they undergo a temporary (elastic) or permanent (plastic) deformation into new shapes. At higher pressure, the particles that fracture could further rearrange and undergo additional deformation. Tablets made from materials that undergo fragmentation are typically less sensitive to weakening when powdered lubricants (i.e., magnesium stearate) are added. Lubricants commonly inhibit bonding between particles, but when the particles fragment, new and clean surfaces are exposed, strengthening the bond. Particles that fragment are also less sensitive to the speed of the compression event. Materials that undergo plastic deformation, are known for creating high-strength compacts at relatively low applied pressures, which stems from the greater number of inter-particulate contact points during the deformation process. That strength, however, Natoli Engineering Company 636.926.8900 info@natoli.com 3 / 6

Equation 1. may decrease when lubricants are added and when the rate of compression increases. Elastic deformation refers to a particle s partial or full recovery to its original shape after compression loading ceases. Time-dependent elastic recovery is called viscoelasticity, and the factors that influence compression time are press speed, turret velocity, compression roller size, and punch head dimensions. TABLET COMPRESSION STUDIES Equation 2. Equation 3. Equation 4. Figure 1. To conduct a compression study, select the tablet s target weight and don t change it. Next, collect samples of tablets made at different compaction forces (low to high) and measure their thickness, weight, breaking force (sometimes called hardness), and friability, as well as their disintegration and dissolution characteristics. Then plot each attribute or characteristic as a function of the compaction force. Figure 1 shows a tabletability profile, which plots tensile strength as a function of the applied compaction pressure. The compaction pressure, which can be calculated from the applied force and cross-sectional area of the punch face (Equation 1), allows you to compare the loading of different sizes of tablets. Tensile strength, which can be calculated from the breaking force and tablet dimensions, allows you to compare the mechanical strength of different sizes of tablets. The tablets for the experiments summarized here were made using round, flat-faced punches and the values were calculated using the Fell-Newton equation [2], where F is the breaking force, D is the diameter of the tablet, and T is the tablet thickness (Equation 2). Compaction pressures of 100 to 200 megapascals (MPa) are typical for pharmaceutical tablets, while pressures greater than 200 MPa are common for dietary supplement tablets due to the very high percentage of active ingredients where a pharmaceutical tablet may only contain less than 10% active and high percentage of binders. There are many factors that will determine the target tablet strength, although 1 to 2 MPa of tensile strength is typically required for the tablet to remain intact through Natoli Engineering Company 636.926.8900 info@natoli.com 4 / 6

Figure 2. Figure 3. post-compaction processes, such as coating, transport/handling, and packaging. From the example in Figure 1, it s clear that from a mechanical strength evaluation, microcrystalline cellulose (MCC) [3] with 0.5 percent magnesium stearate [4] provides the strongest compact. This is mainly due to the plastic deformation characteristics of MCC. The lactose monohydrate [5] with 0.5 percent magnesium stearate also provides a robust tablet at reasonable compaction pressures. But by blending the two excipients it s possible to add multiple functions to the formulation s performance, including plastic and brittle deformation characteristics. A 3-to-1 ratio of lactose-to- MCC provides a slightly stronger tablet than one made from pure lactose. With the evaluation of the mechanical strengths of the tablets at different compaction pressures complete, we can turn to evaluating the solid fraction. It indicates how much of the tablet s total volume is solid material. The solid fraction of a tablet corresponds to the ratio of the tablet s apparent density and absolute density, as measured by a helium picnometer [6]. The tablet s density can be calculated from its weight and volume. The converse of density is porosity the total volume occupied by voids or air and it is calculated by subtracting the solid fraction from 1. See Equations 3 and 4. Figure 2 depicts a compactibility profile, which is the tablet s tensile strength as a function of the solid fraction. The MCC behavior is consistent with the tabletability profile we calculated above and yields the strongest compact, in this case at the lowest solid fraction. The 3-to-1 blend of lactose-to-mcc provides a stronger compact than lactose does at a given solid fraction. Figure 3 depicts the compressibility profile, which assesses how readily the material undergoes a change in volume when Natoli Engineering Company 636.926.8900 info@natoli.com 5 / 6

Figure 4. Figure 5. Figure 6. compressed. As the applied compaction pressure increases, so does the material s solid fraction. At a specific compaction pressure, the MCC yields the lowest solid fraction, whereas the lactose and the 3-to-1 lactose-to-mcc blend provides very similar solid fraction results. Now that we know the compaction characteristics of the excipients, let s add an API to the mix. Figure 4 depicts the tabletability profile of the 1) 3-to-1 lactose-to-mcc blend, 2) the 3-to-1 blend with the addition of 10 percent acetaminophen (APAP), and 3) the 3-to-1 blend with the addition 20 percent APAP. If a tensile strength of 2 MPa is the target value, the 3-to-1 blend without APAP requires only 90 MPa of compaction pressure, while the addition of 10 percent APAP blend requires 120 MPa, and the 20 percent APAP blend requires 180 MPa. Clearly, the APAP diminishes the tablet s strength, so making a tablet containing APAP requires a higher compaction pressure to achieve the target strength. Figure 5 shows the compactibility profile of the 3-to-1 lactose-to-mcc blend and how it changes with the additions of APAP. At a given solid fraction, the addition of APAP diminishes tablet strength. Finally, the compressibility profile in Figure 6 shows similar results for all three combinations. CONCLUSION Advances in compression science continue to help formulators succeed in delivering a branded or generic medicine. And evaluating tabletability, compactibility, and compressibility reveals the fundamental mechanical behavior of your product in a normalized format. This approach can form the basis for developing robust products using only small amounts of material. To learn more about these evaluations and other aspects of tabletting science, contact the Natoli Institute for information about its contract development services and hands-on training, which includes formulation development and scaling up to a manufacturing process. Natoli Engineering Company 636.926.8900 info@natoli.com 6 / 6